临床路径在睫状体冷冻术治疗难治性青光眼中的应用

目的:分析临床路径在睫状体冷冻治疗难治性青光眼中的实施价值。方法:在我科2011-01/12行睫状体冷冻治疗难治性青光眼的患者中,以进入临床路径的23例24眼为路径组,以未采用临床路径的20例20眼为对照组,比较两组患者平均住院日、术前平均住院日、平均住院费用、治愈率、患者满意度指标。结果:两组手术有效率相当(83%vs80%);路径组平均住院日、平均住院费用均少于对照组(4.2dvs8.3d,2138元vs2787元),患者满意度高于对照组(96%vs85%),差异有统计学意义(P<0.05)。结论:在睫状体冷冻治疗难治性青光眼中应用临床路径有利于规范手术操作、确保手术成功,提高工作效率,改善医疗服务质量。

Application of clinical pathway in cyclocryotherapy in treatment of refractory glaucoma

AIM: To analyze the implementation value of clinical path in cyclocryotherapy for refractory glaucoma.

METHODS: Refractory glaucoma patients who underwent cyclocryotherapy treatment in the ophthalmology department from January 2011 to December 2011 were included, 24 eyes of 23 cases were treated with the clinical path, and 20 eyes of 20 cases as control group. An average length of stay, preoperative average length of stay, average cost of hospitalization, the cure rate, and patient satisfaction indicators were compared between two groups

RESULTS: There was no difference in the effective rate of surgery between two groups(83% vs 80%). The average length of stay and average hospital costs were less in path group than the control group(4.2d vs 8.3d, 2138 vs 2 787), but patient satisfaction was higher than the control group(96% vs 85%), and the difference was statistically significant(P <0.05).

CONCLUSION: The clinical pathway in the ciliary body frozen for refractory glaucoma contribute to standardize the surgical procedure to ensure that the operation is successful and improve work efficiency and the quality of medical services.